Equities research analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.13. The company has a 50 day moving average price of $0.01 and a two-hundred day moving average price of $0.02.
Calithera Biosciences Company Profile
Want More Great Investing Ideas?
Read More
- Five stocks we like better than Calithera Biosciences
- The 3 Best Retail Stocks to Shop for in August
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Brinker International Offers a Pullback Opportunity on EPS Miss
- The 3 Best Blue-Chip Stocks to Buy Now
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.